Riot Platforms
RIOT
CleanSpark
CLSK
Eli Lilly and Co
LLY
Fluor
FLR
Tractor Supply
TSCO
US Stock MarketDetailed Quotes
RZLT Rezolute
- 4.810
- -0.110-2.24%
Close Jan 22 16:00 ET
- 4.810
- 0.0000.00%
Post 16:31 ET
278.71MMarket Cap-3.79P/E (TTM)
5.070High4.790Low608.59KVolume4.930Open4.920Pre Close2.97MTurnover1.21%Turnover RatioLossP/E (Static)57.94MShares6.18652wk High2.46P/B241.79MFloat Cap0.92052wk Low--Dividend TTM50.27MShs Float21.110Historical High--Div YieldTTM5.69%Amplitude0.720Historical Low4.878Avg Price1Lot Size
Rezolute News
Optimistic Outlook on Rezolute's RZ358 Clinical Progress Fuels Buy Rating
Rezolute Highlights Promising Phase 2 Ersodetug Results
Rezolute Says It Gets Breakthrough Therapy Designation From US FDA for Ersodetug to Treat Hypoglycemia
Rezolute's Promising Developments in Hyperinsulinism Treatments Justify Buy Rating
Express News | Rezolute Inc: Topline Sunrize Data Expected Second Half of This Year
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying
Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Express News | Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
RZLT Stock Rises on FDA's Orphan Designation for Rare Disease Drug
Sector Update: Health Care Stocks Higher Tuesday Afternoon
Yun Zhong, PhD, Joins Wedbush Securities as Senior Vice President, Equity Research, Biotechnology
Express News | FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (Rz358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
FDA Grants Orphan Drug Designation to Rezolute's Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
Rezolute, Inc. Advances Late-Stage Trials for Rare Disease Therapies
Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading Into 2025?
We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully
Maxim Group Maintains Rezolute(RZLT.US) With Buy Rating, Announces Target Price $12
Rezolute Analyst Ratings
Wedbush Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $12
JMP Securities Maintains Rezolute(RZLT.US) With Buy Rating, Raises Target Price to $8
Trending Stocks
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.